CION Ameerpet
A craniopharyngioma is a benign (non-cancerous) brain tumour, but its position near your child's pituitary gland and optic nerves means it needs careful, expert care. CION's tumour board plans treatment that protects your child's vision, hormones and growth.
A craniopharyngioma is a rare, benign (non-cancerous) brain tumour. It is classed as WHO Grade 1 — the lowest grade — and it does not spread to other organs. It grows from leftover developmental cells near the pituitary gland, the small hormone-control gland at the base of the brain, in an area called the sellar and suprasellar region. It is one of the more common non-glial brain tumours of childhood, most often diagnosed between about 5 and 14 years of age.
Here is the part every parent needs to hear: "benign" does not mean harmless. A craniopharyngioma sits in a crowded, delicate part of the brain — right next to the optic nerves (which carry vision), the pituitary gland (which controls hormones and growth), and the hypothalamus (which controls thirst, temperature, appetite and weight). Even a slow-growing tumour here can affect these functions if it is not treated with care. That is exactly why expert, coordinated treatment matters — even for a tumour that is not cancer.
How CION cares for your child: childhood brain tumours are managed under CION's dedicated pediatric cancer programme, with paediatric specialists leading care. This page explains childhood craniopharyngioma in plain language; for a broader picture, see our guides to brain tumours in children and childhood brain tumours. Adults with this tumour can read our craniopharyngioma page instead.
A craniopharyngioma sits so close to the pituitary gland and hypothalamus that removing every last piece can risk a child's hormones, growth and vision. Because of this, the European Association of Neuro-Oncology (EANO) recommends that vision (ophthalmology) and hormone (endocrine) assessments are done before treatment begins, and that treatment is planned to protect these functions — not just to remove the tumour. The goal of modern childhood care is long-term tumour control with the fewest possible side effects.
In children, the signs of a craniopharyngioma usually appear slowly, over months, because the tumour grows gently and presses on nearby structures bit by bit. This is one reason the diagnosis is often delayed — early signs are easy to mistake for everyday childhood problems. It helps to think of the signs in three groups:
When to get your child checked: a craniopharyngioma is a rare cause of these signs — most headaches, thirst and growth worries have an everyday explanation. But new, persistent morning headaches with vomiting, a change in vision, or a clear drop-off in growth should always be assessed by a doctor, with a brain MRI arranged if needed. Talk to a CION specialist if this sounds like your child.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether your child has just been diagnosed or you want a second opinion before surgery, CION's paediatric tumour board will explain the options — and how each one protects your child's vision, hormones and growth.
Diagnosing a craniopharyngioma well means looking at three things together: the tumour itself, your child's vision, and your child's hormones and growth. At CION, all three assessments are arranged before any treatment decision is made, in line with EANO and NCCN guidance.
MRI is the main test. A contrast MRI shows the tumour's exact position and size, and whether it is solid, fluid-filled (cystic), or a mix of both. It also shows how close the tumour is to the optic nerves, pituitary gland and hypothalamus — essential for planning safe treatment. Flecks of calcium within the tumour, often seen on imaging, are a classic feature of craniopharyngioma in children.
Because the tumour sits on the pituitary gland, blood tests check thyroid, adrenal (cortisol), growth and puberty hormones, plus water-balance status. The team also reviews your child's height and weight history. Many children already have one or more hormone deficiencies at diagnosis; finding these early means they can be safely replaced before treatment, which lowers the risks of surgery and radiation.
A formal eye test — including a visual field test that maps side vision where the child is old enough to co-operate — records exactly how much the tumour is affecting sight. This becomes the baseline against which improvement after treatment is measured.
There is no single "best" treatment for every child. The right plan depends on the tumour's size, whether it is solid or cystic, how close it is to the optic nerves and hypothalamus, and your child's current vision, growth and hormone status. CION's multidisciplinary paediatric tumour board weighs all of this before recommending a path. The modern aim is long-term tumour control with the least possible damage to vision, hormones and growth — which often means a planned combination rather than one aggressive step.
Surgery aims to remove as much of the tumour as can be done safely and to relieve pressure on the optic nerves. Two main approaches are used: the transsphenoidal route (through the nose and sinuses, with no external incision) for suitable tumours, and an open (transcranial) approach for larger or more complex tumours. At CION, all neurosurgery for children is coordinated with accredited neurosurgical partners — CION's paediatric neuro-oncology team plans the overall care, while the surgery itself is performed by partnered neurosurgical specialists. Modern practice often favours a planned partial removal followed by focused radiation, because attempting complete removal near the hypothalamus can cause more harm than good in a growing child.
Radiation is used to control any tumour left after surgery, or as the main treatment when surgery is too risky. CION delivers radiation therapy in-house using precision techniques — IMRT and IGRT, and focused stereotactic radiation for small, well-defined targets — as part of coordinated specialist care. Precise radiation lets us treat the tumour while sparing the nearby optic nerves and healthy brain as much as possible. You can read more about childhood brain tumour treatment and, for the general picture, brain tumour treatment in Hyderabad.
For mainly fluid-filled (cystic) craniopharyngiomas, draining the cyst can quickly relieve pressure and improve vision. Throughout and after treatment, a paediatric endocrinologist manages hormone replacement so your child's thyroid, cortisol, growth, puberty and water balance stay properly supported — this is delivered directly by CION's care team.
Most children treated for a craniopharyngioma go on to grow, learn and lead full, active lives. Because this is a benign tumour, long-term care focuses on two things: keeping the tumour controlled, and keeping your child's hormones, growth and vision well managed.
Because a craniopharyngioma can recur even years after successful treatment, the National Comprehensive Cancer Network (NCCN) and EANO both recommend long-term MRI surveillance for children rather than a fixed end-date for follow-up. A recurrence is not a sign that the first treatment failed — it is a known feature of this tumour, and focused radiation or repeat surgery can usually bring it back under control.
Childhood craniopharyngioma decisions are nuanced and they affect your child for life, so a second opinion is genuinely worthwhile. Consider one if:
CION offers a free written second opinion, with every case reviewed by a multidisciplinary tumour board under our pediatric cancer programme — see our brain tumour second opinion service. You can also call us directly on 18002028726 to talk through your child's scan and report.
Get a free written second opinion from CION's paediatric tumour board — especially valuable before craniopharyngioma surgery, or if radiation options and a hormone assessment have not been discussed.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No. A craniopharyngioma is a benign (non-cancerous) brain tumour, graded WHO Grade 1, and it does not spread to other parts of the body. But "benign" does not mean harmless. In children it grows right next to the pituitary gland, the optic nerves and the hypothalamus — areas that control vision, hormones, growth, appetite and weight. Because of this, even a slow-growing tumour can cause real, lasting problems if it is not treated carefully. The goal of modern care is long-term tumour control while protecting your child's vision, hormones and growth — not treating it like a cancer with chemotherapy. Childhood brain tumours at CION are managed under our pediatric cancer hub.
The most common early signs are headaches (often worse in the morning or with vomiting), vision changes such as bumping into things or squinting, and slowed or stalled growth — a child who stops keeping up on their height chart. Some children develop excessive thirst and frequent urination (diabetes insipidus), or delayed puberty. These signs come on slowly, so they are often mistaken for everyday problems. A craniopharyngioma is a rare cause — but new, persistent headaches with vomiting, a change in vision, or a clear drop-off in growth should always be checked with a doctor and, if needed, a brain MRI.
Treatment is tailored to the tumour's size and position and to your child's vision, growth and hormone status. The two main tools are surgery (to remove or reduce the tumour and relieve pressure) and radiation therapy (often focused/stereotactic radiation or proton-type care for any residual or recurrent tumour). At CION, all neurosurgery is coordinated with accredited neurosurgical partners. CION directly delivers the radiation therapy (IMRT/IGRT), imaging, hormone and supportive care, and the multidisciplinary tumour board review that decides the safest plan. Modern practice, in line with EANO and NCCN, often favours a planned partial removal plus focused radiation to protect the hypothalamus and vision.
Often, yes. The tumour and its treatment can affect the pituitary gland, which controls growth, thyroid, cortisol (steroid), puberty and water balance. Many children need hormone replacement — for example growth hormone, thyroid hormone, cortisol and sometimes desmopressin for diabetes insipidus. This is managed by a paediatric endocrinologist as part of the care team. With the right replacement and regular monitoring, most children grow, learn and thrive. Doses are adjusted as your child grows and through puberty, so hormone follow-up is a normal, ongoing part of care rather than a sign anything has gone wrong.
Yes — craniopharyngiomas can recur, especially when the whole tumour could not be safely removed (which is common, because complete removal can risk vision and the hypothalamus). This is why long-term MRI surveillance is essential, continuing for many years. If the tumour regrows, options include further focused radiation, repeat surgery (coordinated with neurosurgical partners), or drainage of a fluid-filled (cystic) part. Recurrence is not a sign the first treatment failed — it is a known feature of this tumour, and there are effective ways to bring it back under control.
A second opinion is especially worthwhile for childhood craniopharyngioma, because the decisions are nuanced and affect your child for life. Seek one if: aggressive total removal is being recommended without discussing the risk to vision, growth and the hypothalamus; radiation options (such as focused/stereotactic radiation) have not been explained; or an endocrine and ophthalmology assessment was not arranged before treatment. CION offers a free written second opinion through our brain tumour second opinion service, with every case reviewed by a multidisciplinary tumour board and coordinated under our pediatric cancer hub.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.